Steven R. Pliszka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Steven R. Pliszka has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Carroll W. Hughes
2 shared publications- David C. Glahn
Department of Psychiatry, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115;Harvard Medical School, Boston, MA 02115
2 shared publications David Glahn
Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas
2 shared publicationsGraham J. Emslie
2 shared publications- Jesse C. Bledsoe
Michigan State University, Consortium for Neurodevelopmental Study, East Lansing, MI 48824, USA
2 shared publications M. Lynn Crismon
2 shared publications
Latest Publications
- 8 April 2025
- Published by Elsevier in The Lancet Psychiatry
- Vol. 12 (5) , 319-320
Cardiovascular effects of ADHD medications
- 8 April 2025
- Published by Elsevier in The Lancet Psychiatry
- Vol. 12 (5) , 319-320
Cardiovascular effects of ADHD medications
- 10 June 2022
- Published by Elsevier in Child and Adolescent Psychiatric Clinics of North America
- Vol. 31 (3) , 569-581
A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder
- 10 June 2022
- Published by Elsevier in Child and Adolescent Psychiatric Clinics of North America
- Vol. 31 (3) , 569-581
A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (10) , S124
2.5 PSYCHOPHARMACOLOGICAL TREATMENT OF COMORBID PSYCHIATRIC DISORDERS IN PATIENTS WITH ADHD
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (10) , S124
2.5 PSYCHOPHARMACOLOGICAL TREATMENT OF COMORBID PSYCHIATRIC DISORDERS IN PATIENTS WITH ADHD
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S312
NEW FINDINGS FROM THE MULTIMODAL TREATMENT OF ADHD (MTA) STUDY FOLLOW-UP
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S312
NEW FINDINGS FROM THE MULTIMODAL TREATMENT OF ADHD (MTA) STUDY FOLLOW-UP
- 1 October 2017
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 56 (10) , S328
17.3 Neuroimaging of Children With Attention-Deficit/Hyperactivity Disorder With and Without Aggression
- 1 October 2017
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 56 (10) , S328
17.3 Neuroimaging of Children With Attention-Deficit/Hyperactivity Disorder With and Without Aggression
- 1 October 2017
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 56 (10) , S170
1.53 Clinically Meaningful Improvements With DR/ER-MPH in At-Home Functional Impairment During the Early Morning, Late Afternoon, and Evening in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
- 1 October 2017
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 56 (10) , S170
1.53 Clinically Meaningful Improvements With DR/ER-MPH in At-Home Functional Impairment During the Early Morning, Late Afternoon, and Evening in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
- 1 January 2016
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 14 (1) , 46-53
Attention-Deficit Hyperactivity Disorder Across the Lifespan
Up to 10% of school-age children have attention-deficit hyperactivity disorder (ADHD), which often persists into adulthood. ADHD can be associated with significant comorbidity of disruptive, mood, and anxiety disorders. Although many children with ADHD have good long-term outcomes, a significant subset has substance abuse, antisocial behavior, and mood disorders as adults. Pharmacotherapy with stimulants, atomoxetine, and alpha-agonists is highly effective in the short term; behavior therapy is valuable as an adjunct to medication or to address comorbid conditions. Multiple genes each likely contribute small effects to the risk of ADHD. Neuroimaging studies suggest that individuals with ADHD have insufficient activation of cortical attention networks, reduced activity of ventral striatal reward systems, and dysregulated control of the default mode network. No neuroimaging technique is yet useful clinically. More long-term studies of both medication and psychosocial interventions are needed to improve outcomes.
- 1 January 2016
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 14 (1) , 46-53
Attention-Deficit Hyperactivity Disorder Across the Lifespan
Up to 10% of school-age children have attention-deficit hyperactivity disorder (ADHD), which often persists into adulthood. ADHD can be associated with significant comorbidity of disruptive, mood, and anxiety disorders. Although many children with ADHD have good long-term outcomes, a significant subset has substance abuse, antisocial behavior, and mood disorders as adults. Pharmacotherapy with stimulants, atomoxetine, and alpha-agonists is highly effective in the short term; behavior therapy is valuable as an adjunct to medication or to address comorbid conditions. Multiple genes each likely contribute small effects to the risk of ADHD. Neuroimaging studies suggest that individuals with ADHD have insufficient activation of cortical attention networks, reduced activity of ventral striatal reward systems, and dysregulated control of the default mode network. No neuroimaging technique is yet useful clinically. More long-term studies of both medication and psychosocial interventions are needed to improve outcomes.
- Open Access
- 16 April 2014
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 3 (2) , 416-431
Cortical Volume Alterations in Conduct Disordered Adolescents with and without Bipolar Disorder
Background: There is increasing evidence that bipolar disorder (BD) and conduct disorder (CD) are co-occurring disorders. Magnetic resonance imaging has revealed differences in the structure and function of the frontal cortex in these disorders when studied separately; however, the impact of BD comorbidity on brain structure in adolescents with CD has not yet been examined. Method: We conducted an optimized voxel based morphometry (VBM) study of juvenile offenders with the following diagnoses: conduct disorder with comorbid bipolar disorder (CD-BD; n = 24), conduct disorder without bipolar disorder (CD; n = 24) and healthy controls (HC, n = 24). Participants were 13–17 years of age, in a residential treatment facility for repeat offenders. The three groups in this study were similar in age, gender, socioeconomic status and ethnicity. Results: We found CD-BD subjects had decreased volume relative to controls at the voxel level in the right medial prefrontal cortex (PFC). Using a Threshold-Free Cluster Enhancement (TFCE) technique, the CD-BD subjects had significantly decreased volumes of the right medial prefrontal cortex and portions of the superior and inferior frontal gyrus, anterior cingulate and temporal gyrus. The CD subjects did not have differences in brain volume compared to control subjects or CD-BD subjects. Conclusions: Our findings suggest the comorbidity between CD and BD is associated with neurobiological impact namely volumetric differences from healthy controls. Furthermore subjects with this comorbidity had poorer lifetime functioning, more mood and attentional dysfunction, and more medication exposure than subjects with CD who were not BD.
- 16 April 2014
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 3 (2) , 416-431
Open AccessCortical Volume Alterations in Conduct Disordered Adolescents with and without Bipolar Disorder
Background: There is increasing evidence that bipolar disorder (BD) and conduct disorder (CD) are co-occurring disorders. Magnetic resonance imaging has revealed differences in the structure and function of the frontal cortex in these disorders when studied separately; however, the impact of BD comorbidity on brain structure in adolescents with CD has not yet been examined. Method: We conducted an optimized voxel based morphometry (VBM) study of juvenile offenders with the following diagnoses: conduct disorder with comorbid bipolar disorder (CD-BD; n = 24), conduct disorder without bipolar disorder (CD; n = 24) and healthy controls (HC, n = 24). Participants were 13–17 years of age, in a residential treatment facility for repeat offenders. The three groups in this study were similar in age, gender, socioeconomic status and ethnicity. Results: We found CD-BD subjects had decreased volume relative to controls at the voxel level in the right medial prefrontal cortex (PFC). Using a Threshold-Free Cluster Enhancement (TFCE) technique, the CD-BD subjects had significantly decreased volumes of the right medial prefrontal cortex and portions of the superior and inferior frontal gyrus, anterior cingulate and temporal gyrus. The CD subjects did not have differences in brain volume compared to control subjects or CD-BD subjects. Conclusions: Our findings suggest the comorbidity between CD and BD is associated with neurobiological impact namely volumetric differences from healthy controls. Furthermore subjects with this comorbidity had poorer lifetime functioning, more mood and attentional dysfunction, and more medication exposure than subjects with CD who were not BD.
- 1 June 2012
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (6) , 557-559
Tracking the Development of Bipolar Disorder in Childhood
- 1 June 2012
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (6) , 557-559
Tracking the Development of Bipolar Disorder in Childhood
- 19 February 2009
- Published by Cambridge University Press (CUP)
- p. 344-364
Neuroimaging of treatment effects in developmental neuropsychiatric disorders
Neuroimaging in Developmental Clinical Neuroscience - February 2009
- 19 February 2009
- Published by Cambridge University Press (CUP)
- p. 344-364
Neuroimaging of treatment effects in developmental neuropsychiatric disorders
Neuroimaging in Developmental Clinical Neuroscience - February 2009